Patents by Inventor Andrew James Greenland

Andrew James Greenland has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7183061
    Abstract: The invention relates to an insect steroid receptor protein which is capable of acting as a gene switch which is responsive to a chemical inducer enabling external control of the gene.
    Type: Grant
    Filed: June 25, 2003
    Date of Patent: February 27, 2007
    Assignee: Syngenta Limited
    Inventors: Ian Jepson, Alberto Martinez, Andrew James Greenland
  • Publication number: 20040157287
    Abstract: The present invention relates to novel AlcR regulatory elements and nucleic acid sequences coding therefor, and their use in controlling gene expression in organisms such as plants. DNA constructs containing such nucleic acids, in particular, expression cassettes comprising inducible promoter elements and regulatory elements of the invention, which are capable of acting as “gene switches”, form further aspects of the invention.
    Type: Application
    Filed: August 11, 2003
    Publication date: August 12, 2004
    Inventors: Andrew James Greenland, Ian Jepson, Alberto Martinez, Lynne Marie Roxbee Cox
  • Publication number: 20040058369
    Abstract: The invention relates to an insect steroid receptor protein which is capable of acting as a gene switch which is responsive to a chemical inducer enabling external control of the gene.
    Type: Application
    Filed: June 25, 2003
    Publication date: March 25, 2004
    Inventors: Ian Jepson, Alberto Martinez, Andrew James Greenland
  • Publication number: 20040045053
    Abstract: A recombinant nucleic acid which comprises a promoter sequence of the ZmC5 gene in maize, or a variant or fragment thereof, which acts as a promoter in pollen.
    Type: Application
    Filed: December 5, 2002
    Publication date: March 4, 2004
    Inventors: Andrew James Greenland, Hilary Joan Rogers, Patrick Joseph Hussey
  • Patent number: 6610828
    Abstract: The invention relates to an insect steroid receptor protein which is capable of acting as a gene switch which is responsive to a chemical inducer enabling external control of the gene.
    Type: Grant
    Filed: May 3, 2000
    Date of Patent: August 26, 2003
    Assignee: Syngenta Limited
    Inventors: Ian Jepson, Alberto Martinez, Andrew James Greenland
  • Patent number: 6599514
    Abstract: Antifungal compositions having enhanced antifungal activity comprising an antifungal agent and a food additive are described. Also described are a method for inhibiting fungal growth using the compositions with enhanced activity and the use of a food additive to enhance the antifungal properties of an antifungal agent.
    Type: Grant
    Filed: December 21, 1999
    Date of Patent: July 29, 2003
    Assignee: Syngenta Limited
    Inventors: Andrew James Greenland, Angel Manuel Fuentes Mateos
  • Patent number: 6379945
    Abstract: The invention relates to an insect steroid receptor protein which is capable of acting as a gene switch which is responsive to a chemical inducer enabling external control of the gene.
    Type: Grant
    Filed: May 24, 1996
    Date of Patent: April 30, 2002
    Assignee: Zeneca Limited
    Inventors: Ian Jepson, Alberto Martinez, Andrew James Greenland
  • Publication number: 20010049833
    Abstract: Disclosed are isolated DNA constructs including (a) a first DNA sequence including either an inducible promoter sequence responsive to the presence or absence of an exogenous inducer or a developmental gene promoter capable of initiating gene expression in a selected tissue or at a selected stage of development of an organism; (b) a second DNA sequence including a DNA sequence coding for a protease enzyme operably linked and under the control of the promoter sequence specified at (a); whereby the presence or absence of the exogenous inducer or the activation of the developmental gene promoter specified at (a) results in expression of the protease enzyme. These constructs are preferably rendered reversible by the presence of further elements. These constructs can be used in plant or mammalian cells for disruption of cell function, controlling senescence and modifying the metabolism of stored proteins.
    Type: Application
    Filed: February 14, 2001
    Publication date: December 6, 2001
    Inventors: Andrew James Greenland, Didier Rene Philippe Thomas, Ian Jepson
  • Patent number: 6228643
    Abstract: A promoter comprising the DNA sequence of an oil seed rape cysteine protease gene promoter of class 1, 2 or 6 is described. The promoter may be used in an expression system for at least the tissue or tissues of a germinating seedling or developing grain or plant (e.g. in the root, cotyledons, leaves and stem). In a preferred embodiment, the expression system comprises a disrupter gene fused to a promoter according to the present invention.
    Type: Grant
    Filed: March 22, 1997
    Date of Patent: May 8, 2001
    Assignee: Zeneca Limited
    Inventors: Andrew James Greenland, Didier Rene Philippe Thomas, Ian Jepson
  • Patent number: 6172279
    Abstract: Male sterility is imparted to a plant by a cascade of gene sequences which expresses a protein which disrupts the biosynthesis of viable pollen. Expression of the disrupter protein is restricted to male parts of the plant by an upstream promoter sequence which is specific to male flowers, the male specific promoter being under control of an operator sequence. The cascade also includes a gene encoding a repressor protein specific for that operator. Expression of the repressor protein is under control of a chemically inducible promoter which is inducible by the application to the plant by, spraying or like process, of an exogenous chemical. In the absence of the exogenous chemical inducer, no repressor protein is expressed, resulting in expression of the disrupter protein and, consequently, male sterility.
    Type: Grant
    Filed: November 7, 1995
    Date of Patent: January 9, 2001
    Assignee: Zeneca Limited
    Inventors: Ian George Bridges, Simon William Jonathan Bright, Andrew James Greenland, Wolfgang Walter Schuch
  • Patent number: 6066456
    Abstract: The chemically-inducible 27 kD subunit of the enzyme glutathione-S-transferase, isoform II (GST-II-27) and sequences encoding it are provided. In particular, a genomic DNA sequence encoding the gene promoter for the GST-II-27 subunit is provided. Then linked to an exogenous gene and introduced into a plant by transformation, and GST-II-27 promoter provides a means for the external regulation of expression of that exogenous gene. Transformation with DNA encoding glutathione-S-transferase polypeptides produces herbicide resistance transgenic plants.
    Type: Grant
    Filed: March 26, 1998
    Date of Patent: May 23, 2000
    Assignee: Zeneca Limited
    Inventors: Ian George Bridges, Simon William Jonathan Bright, Andrew James Greenland, David Charles Holt, Ian Jepson, Wolfgang Walter Schuch
  • Patent number: 6037524
    Abstract: A promoter derived from an SHH gene, especially the SHH gene of Arabidopsis thaliana which is capable of directing expression on a variety of operator genes in both monocotyledonous and dicotyledonous plants. The promoter of the invention may be used for directing expression of pathogen resistance genes to disease or wound sites.
    Type: Grant
    Filed: October 9, 1997
    Date of Patent: March 14, 2000
    Assignee: Zeneca Limited
    Inventors: Andrew James Greenland, John Draper, Mark Skipsey, Simon Warner
  • Patent number: 6010887
    Abstract: Pseudo-operator sequences may be located in (or inserted into) plant genomes and utilized to drive expression of foreign genes. These pseudo-operator sequences are nucleotide sequences which are present at a suitable location in a gene at which repressor binding will lead to inhibitation or enhancement of gene expression. The disclosed technique permits the design of altered specificity repressors, which bind the pseudo-operators.
    Type: Grant
    Filed: September 14, 1994
    Date of Patent: January 4, 2000
    Assignees: Imperial Chemical Industries PLC, University of Leicester
    Inventors: Ian George Bridges, Simon William Jonathan Bright, Andrew James Greenland, Wolfgang Walter Schuch, Andrew Merryweather, David Pioli
  • Patent number: 5965387
    Abstract: A chemically inducible gene promoter sequence, and particularly, but not exclusively, a chemically inducible gene promoter sequence based on cis regulatory elements from the maize glutathione S-transferase 27 (GST-27) gene. In a preferred embodiment, the promoter sequence is operatively linked or fused to a gene or series of genes whereby expression of the gene or series of genes may be controlled by application of an effective exogenous inducer.
    Type: Grant
    Filed: September 23, 1996
    Date of Patent: October 12, 1999
    Assignee: Zeneca Limited
    Inventors: Ian Jepson, Andrew James Greenland, Michael Bevan, Hilary Sheppard
  • Patent number: 5866792
    Abstract: The chemically-inducible 27 kD subunit of the enzyme glutathione-S-transferase, isoform II (GST-II-27) and sequences encoding it are provided. In particular, a genomic DNA sequence encoding the gene promoter for the GST-II-27 subunit is provided. Then linked to an exogenous gene and introduced into a plant by transformation, and GST-II-27 promoter provides a means for the external regulation of expression of that exogenous gene. Transformation with DNA encoding glutathione-S-transferase polypeptides produces herbicide resistance transgenic plants.
    Type: Grant
    Filed: June 17, 1996
    Date of Patent: February 2, 1999
    Assignee: Zeneca Limited
    Inventors: Ian George Bridges, Simon William Jonathan Bright, Andrew James Greenland, David Charles Holt, Ian Jepson, Wolfgang Walter Schuch
  • Patent number: 5808034
    Abstract: Male sterility is imparted to a plant by a cascade of gene sequences which expresses a protein which disrupts the biosynthesis of viable pollen. Expression of the disrupter protein is restricted to male parts of the plant by an upstream promoter sequence which is specific to male flowers, the male specific promoter being under control of an operator sequence. The cascade also includes a gene encoding a repressor protein specific for that operator. Expression of the repressor protein is under control of a chemically inducible promoter which is inducible by the application to the plant by, spraying or like process, of an exogenous chemical. In the absence of the exogenous chemical inducer, no repressor protein is expressed, resulting in expression of the disrupter protein and, consequently, male sterility.
    Type: Grant
    Filed: August 22, 1994
    Date of Patent: September 15, 1998
    Assignee: Zeneca Limited
    Inventors: Ian George Bridges, Simon William Jonathan Bright, Andrew James Greenland, Wolfgang Walter Schuch